HealthResearchers Develop Anti-Cancer Drug to Treat Acute Myeloid Leukemia Revumenib sheds light on AML patients as the drug potentially treats their cancer. A group of researchers conducted phase one of clinical trials between 2019 to 2022 for an anti-cancer drug on patients living with acute myeloid leukemia (AML).by Inno Flores
Healthy Living/WellnessMidostaurin In AML Improves Survival In Newly Diagnosed AML Patientsby Rina Marie Doctor
Leader of Furry Hackers Raided by Feds Months After Attack on Creators of Project 2025, Former Member Claims